Tags

Type your tag names separated by a space and hit enter

Social media use and vaccine hesitancy in the European Union.
Vaccine. 2022 03 25; 40(14):2215-2225.V

Abstract

Vaccine hesitancy can hinder the successful roll-out of vaccines. This paper examines COVID-19 vaccine hesitancy in the European Union, drawing from a large-scale cross-national survey covering all 27 EU Member States, carried out between February and March 2021 (n = 29,755). We study the determinants of vaccine hesitancy, focusing on the role of social media use. In multivariate regression models, we find statistically significant (p < 0.05) impacts on vaccine hesitancy of heavy use of social media and using social media as a main source of news. However, the effect of social media and the drivers of vaccine hesitancy vary depending on the reason for hesitancy. Most notably, hesitancy due to health concerns is mainly driven by physical health status and less by social media use, while views that COVID-19 risks are exaggerated (or that COVID-19 does not exist) are more common among men, people in good health, and those using social media as their main source of news.

Links

PMC Free PDF

Authors+Show Affiliations

Mascherini M
Eurofound (European Foundation for the Improvement of Living and Working Conditions, Wyattville Road, Loughlinstown, Co. Dublin, D18 KP65, Ireland). Electronic address: massimiliano.mascherini@eurofound.europa.eu.
Nivakoski S
Eurofound (European Foundation for the Improvement of Living and Working Conditions, Wyattville Road, Loughlinstown, Co. Dublin, D18 KP65, Ireland).

MeSH

COVID-19COVID-19 VaccinesEuropean UnionHumansMaleSARS-CoV-2Social MediaVaccination Hesitancy

Pub Type(s)

Journal Article

Language

eng

PubMed ID

35249775

Citation

Mascherini, Massimiliano, and Sanna Nivakoski. "Social Media Use and Vaccine Hesitancy in the European Union." Vaccine, vol. 40, no. 14, 2022, pp. 2215-2225.
Mascherini M, Nivakoski S. Social media use and vaccine hesitancy in the European Union. Vaccine. 2022;40(14):2215-2225.
Mascherini, M., & Nivakoski, S. (2022). Social media use and vaccine hesitancy in the European Union. Vaccine, 40(14), 2215-2225. https://doi.org/10.1016/j.vaccine.2022.02.059
Mascherini M, Nivakoski S. Social Media Use and Vaccine Hesitancy in the European Union. Vaccine. 2022 03 25;40(14):2215-2225. PubMed PMID: 35249775.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Social media use and vaccine hesitancy in the European Union. AU - Mascherini,Massimiliano, AU - Nivakoski,Sanna, Y1 - 2022/03/03/ PY - 2021/06/01/received PY - 2022/01/26/revised PY - 2022/02/15/accepted PY - 2022/3/8/pubmed PY - 2022/4/1/medline PY - 2022/3/7/entrez KW - COVID-19 KW - Hesitancy KW - Hesitancy reasons KW - News sources KW - Social media KW - Vaccine SP - 2215 EP - 2225 JF - Vaccine JO - Vaccine VL - 40 IS - 14 N2 - Vaccine hesitancy can hinder the successful roll-out of vaccines. This paper examines COVID-19 vaccine hesitancy in the European Union, drawing from a large-scale cross-national survey covering all 27 EU Member States, carried out between February and March 2021 (n = 29,755). We study the determinants of vaccine hesitancy, focusing on the role of social media use. In multivariate regression models, we find statistically significant (p < 0.05) impacts on vaccine hesitancy of heavy use of social media and using social media as a main source of news. However, the effect of social media and the drivers of vaccine hesitancy vary depending on the reason for hesitancy. Most notably, hesitancy due to health concerns is mainly driven by physical health status and less by social media use, while views that COVID-19 risks are exaggerated (or that COVID-19 does not exist) are more common among men, people in good health, and those using social media as their main source of news. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/35249775/Social_media_use_and_vaccine_hesitancy_in_the_European_Union_ DB - PRIME DP - Unbound Medicine ER -